Zoetis Inc. $ZTS Stock: Mill Capital Management LLC Trims Position

Mill Capital Management LLC reduced its position in shares of Zoetis Inc. (NYSE:ZTS) by 6.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 162,288 shares of the company’s stock after selling 11,701 shares during the period. Mill Capital Management LLC’s holdings in Zoetis were worth $11,333,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bank Pictet & Cie Europe AG lifted its holdings in shares of Zoetis by 0.5% in the 3rd quarter. Bank Pictet & Cie Europe AG now owns 343,310 shares of the company’s stock worth $23,973,000 after buying an additional 1,750 shares during the period. Prime Capital Investment Advisors LLC bought a new stake in shares of Zoetis in the third quarter valued at about $267,000. V Square Quantitative Management LLC lifted its stake in Zoetis by 8.0% in the third quarter. V Square Quantitative Management LLC now owns 16,854 shares of the company’s stock worth $1,177,000 after acquiring an additional 1,254 shares during the period. Moody National Bank Trust Division lifted its stake in Zoetis by 108.5% in the third quarter. Moody National Bank Trust Division now owns 15,927 shares of the company’s stock worth $1,112,000 after acquiring an additional 8,288 shares during the period. Finally, Rockland Trust Co. lifted its stake in Zoetis by 19.8% in the third quarter. Rockland Trust Co. now owns 244,065 shares of the company’s stock worth $17,043,000 after acquiring an additional 40,294 shares during the period. 92.80% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ZTS shares. Cantor Fitzgerald set a $94.00 target price on shares of Zoetis in a research report on Tuesday, August 25th. Citigroup lowered their price target on shares of Zoetis from $112.00 to $96.00 and set a “buy” rating for the company in a research report on Tuesday, August 11th. The Goldman Sachs Group initiated coverage on shares of Zoetis in a research report on Friday, October 16th. They issued a “neutral” rating and a $74.00 price target for the company. Barclays dropped their price objective on shares of Zoetis from $136.00 to $85.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 1st. Finally, Zacks Research lowered shares of Zoetis from a “hold” rating to a “strong sell” rating in a report on Monday, August 10th. Seven investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $98.07.

Zoetis Trading Down 0.2%

Shares of NYSE:ZTS opened at $80.88 on Tuesday. The company has a market capitalization of $33.42 billion, a PE ratio of 12.31, a P/E/G ratio of 1.20 and a beta of 0.74. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87. Zoetis Inc. has a 12-month low of $68.77 and a 12-month high of $147.93. The business’s fifty day simple moving average is $74.58 and its 200-day simple moving average is $94.83.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.02. The firm had revenue of $2.47 billion during the quarter, compared to analysts’ expectations of $2.50 billion. Zoetis had a return on equity of 74.89% and a net margin of 27.49%. The firm’s quarterly revenue was down .2% on a year-over-year basis. During the same period in the prior year, the business posted $1.76 EPS. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, equities research analysts predict that Zoetis Inc. will post 6.14 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 1st. Shareholders of record on Friday, October 30th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.6%. The ex-dividend date is Friday, October 30th. Zoetis’s payout ratio is 34.93%.

Zoetis Company Profile

Zoetis Inc is a global animal health company that develops, manufactures and markets medicines, vaccines, diagnostics, genetic products and related services for animals. Its offerings support the prevention, diagnosis and treatment of disease in both companion animals, including dogs, cats and horses, and livestock such as cattle, swine, poultry and fish.

The company’s product portfolio includes prescription medicines, parasiticides, vaccines, veterinary diagnostics and animal genetics.